Recommendations for use of ezetimibe and/or PCSK9 inhibitors in patients with elevated LDL-C
Sign Up to like & getrecommendations! Published in 2022 at "Annals of Internal Medicine"
DOI: 10.7326/j22-0060
Abstract: SOURCE CITATION Hao Q, Aertgeerts B, Guyatt G, et al. PCSK9 inhibitors and ezetimibe for the reduction of cardiovascular events: a clinical practice guideline with risk-stratified recommendations. BMJ. 2022;377:e069066. 35508320. read more here.
Keywords: inhibitors patients; use ezetimibe; pcsk9 inhibitors; recommendations use ... See more keywords